REFERENCES
- Piedbois P., Buyse M., Kemeny N., Rougier P., Carlson R., Allen-Mersh T., O'Connell M., Chang A., Sondak U., Kemeny M., Levy E. Meta-analysis group in cancer. Reappraisal of hepatic arterial infusion in the treatment on non-resectable liver metastases from colorectal cancer. J. Natl. Cancer. Inst. 1996; 88: 252–82
- Gray B., Anderson J., Burton M., et al. Regression of liver metastases following treatment with yttrium90 microspheres. Aust. N.Z. J. Surg. 1992; 62: 105–110
- Gray B., Burton M A., Kelleher D., et al. Selective internal radiation (SIR) therapy for treatment of liver metastases: Measurement of response rate. Surg Oncol. 1989; 42: 192–196
- Gray B., Van Hazel G., Anderson J., et al. Randomized trial of SIR-Spheres plus chemotherapy versus chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Annals Oncol. 2001; 12: 1711–1720
- Lau W., Leung T., Ho S., et al. Treatment of inoperable hepatocellular carcinoma wit yttrium-90 microspheres. A phase 1 and 2 study. Br J Cancer 1994; 70: 994–999
- Burton M A, Kelleher D K., Codde J P, et al. Alteration of experimental liver tumour blood flow. I. Effects of phenylephrine and vasopressin. Cancer J 1990; 3: 346–350
- Grady E. Internal radiation therapy of hepatic cancer. Dis Colon Rectum. 1979; 22: 371–375
- Van Hazel G., et al. Randomised phase 2 trial of SIR-Spheres® plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Onc. 2004; 88: 78–85